Skip to content
Home/Companies/Biotech/AgeX Therapeutics

AgeX Therapeutics

Biotech·US·Exited 2018·Held 1yr
Entry
2017
Hold
1yr
Exit
2018

Who owns AgeX Therapeutics?

AgeX Therapeutics was owned by KIZOO Technology Capital through KIZOO Evergreen (Balance Sheet) (2007 vintage) from 2017 to 2018, exited via IPO.

Hand-verified · updated 2026-07-07

KIZOO Technology Capital
Investor
KIZOO Technology Capital
KIZOO Evergreen (Balance Sheet) · 2007 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
MOIC
Exit Year
2018
Track AgeX Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy AgeX Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on AgeX Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue